Phase Holographic Imaging PHI AB (“PHI” or the “Company”) today announces that Patrik Eschricht, former CEO of PHI, will come back as CEO of the Company, effective immediately. He returns to the role he held during 2023 and most of 2024. Ivan Jurkovic, who has been acting CEO since February 2025, will support a smooth transition […]
HP is teaming up with Tecan, a global leader in laboratory automation for life sciences and diagnostics, to launch the Duo Digital DispenserTM, a new solution designed to simplify how researchers isolate individual cells and develop new therapeutics. Powered by HP’s inkjet technology, Duo combines the capabilities of the D300e Digital Dispenser and the Uno Single Cell DispenserTM, […]
Partnership with SCINCO strengthens international sales and technical support channels in key region as part of ongoing global expansion Cambridge, UK: CN Bio, a leading provider of Organ-on-a-chip (OOC) systems and solutions that accelerate drug discovery and development workflows, today announced a strategic partnership with SCINCO, a specialist scientific instrument company based in South Korea. The […]
Partnership aims at developing next-generation microphysiological systems (MPS)-on-a-chip through multipartner collaboration program Modular, scalable MPS platform envisions unprecedented accuracy in simulating human body responses, providing reliable and high-quality training data for AI models Aiming to enhance drug discovery, expedite drug candidate development, deliver safer, more effective treatments to patients, and reduce animal testing Darmstadt, Germany […]
NextCell Pharma AB’s (“NextCell” or “the Company”) has entered into a strategic collaboration with Fujifilm Irvine Scientific Inc. to bring together their core competences in mesenchymal stromal cells (MSCs) and raw materials for the life science sector. The aim of the collaboration is to provide researchers and developers in the cell therapy field with an […]
BEACHWOOD, Ohio — Trailhead Biosystems Inc. (TrailBio.com), a biotechnology company pioneering the creation of iPSC-derived human cells at scale for drug discovery and cell therapy, is pleased to announce the appointment of David Llewellyn, PhD, MBA as its new Chief Executive Officer, and as a member of its Board of Directors. Dr. Llewellyn succeeds Jan Jensen, PhD, who […]
Morpho Biotech announces it has signed a distribution agreement with MACHEREY-NAGEL (MN) to distribute their Bioanalysis portfolio in the Netherlands as of July 1st. MN is an innovative international company for chemical and biomolecular analysis. The Bioanalysis portfolio of MN consists of efficient and reliable kits for RNA, DNA and protein purification from various sample […]
Research focuses on targeted protein degradation and antibody-drug conjugate as promising modalities for developing next-generation cancer therapies that may improve patient outcomes SEOUL, South Korea — Agilent Technologies Inc. (NYSE: A) announced the recent signing of a Memorandum of Understanding (MOU) with Ubix Therapeutics to accelerate highly targeted cancer therapy research and development in South Korea over […]
PLEASANTON, Calif. — 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced that it has reached a settlement agreement with Bruker Corporation, successfully resolving all outstanding worldwide patent litigation and disputes between the two companies. As part of the settlement, 10x expects that Bruker will pay $68 million in equal quarterly installments between […]
ST. PAUL, Minn. — ScaleReady, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation (NASDAQ: TECH) and CellReady announced today three G-Rex Grants that have been awarded to faculty members at the University of Southern California (USC) and the Children’s Hospital of Los Angeles (CHLA). The funding totaling $1,025,000 will support the translation of various cell and […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
